Author

J.-B. Assie

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

C. Blanquart· 1 shared C. Meiller· 1 shared D. Jean· 1 shared E. Raspe· 1 shared F. Galateau-Salle· 1 shared F. Libert· 1 shared J. P. Van Meerbeeck· 1 shared M. Remmelink· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Blanquart

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of malignant pleural mesotheliomas to CDK4/6 inhibition

S. Paternot, E. Raspe, C. Meiller, M. Tarabichi, J.-B. Assie, F. Libert, M. Remmelink, X. Bisteau, P. Pauwels, Y. Blum, N. Le Stang, S. Tabone-Eglinger, F. Galateau-Salle, C. Blanquart, J. P. Van Meerbeeck, , P. P. Roger

This study shows that CDK4 phosphorylation predicts sensitivity of malignant pleural mesothelioma to CDK4/6 inhibitors, with 80% of tumors expressing phosphorylated CDK4.

bioRxiv · Apr 11, 2022Cancer Biology